Trial Profile
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinacalcet for the Treatment of Hypercalcaemia in Subjects With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Hypercalcaemia; Primary hyperparathyroidism
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 03 Jun 2014 New trial record
- 04 Nov 2013
- 19 Jan 2012